Patents by Inventor Norman A. Mazer

Norman A. Mazer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IN SILICO PREDICTIONS OF AMYLOID-RELATED IMAGING ABNORMALITIES
    Publication number: 20230360721
    Abstract: A dosage of an active ingredient in a treatment that is being provided to or that is being considered for provision to a subject is identified. A level of local amyloid beta is predicted based on the dosage of the active ingredient. A severity of amyloid-related imaging abnormalities (ARIA) manifested as hyperintensities on T2-weighted fluid attenuated inversion recovery (FLAIR) images (ARIA-E) is predicted based on the predicted removal of local amyloid beta, where predicting severity of ARIA-E includes predicting an extent of vascular wall disturbance. A result corresponding to the predicted ARIA-E severity is output.
    Type: Application
    Filed: April 27, 2023
    Publication date: November 9, 2023
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Roxana Aldea, Hans Peter Grimm, Norman A. Mazer
  • Administration of non-oral androgenic steroids to women
    Patent number: 8551516
    Abstract: The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: October 8, 2013
    Assignee: Actavis, Inc.
    Inventors: Theresa Rosario-Jansen, Norman A. Mazer
  • Administration of non-oral androgenic steroids to women
    Publication number: 20070190120
    Abstract: The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
    Type: Application
    Filed: February 15, 2007
    Publication date: August 16, 2007
    Inventors: Theresa Rosario-Jansen, Norman Mazer
  • Administration of non-oral androgenic steroids to women
    Patent number: 7186706
    Abstract: The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: March 6, 2007
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Theresa Rosario-Jansen, Norman A. Mazer
  • Administration of non-oral androgenic steroids to women
    Publication number: 20030153540
    Abstract: The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
    Type: Application
    Filed: October 22, 2002
    Publication date: August 14, 2003
    Inventors: Theresa Rosario-Jansen, Norman A. Mazer
  • Administration of non-oral androgenic steroids to women
    Patent number: 6583129
    Abstract: The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: June 24, 2003
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Norman A. Mazer, Theresa Rosario-Jansen
  • Methods for providing testosterone and optionally estrogen replacement therapy to women
    Patent number: 5460820
    Abstract: A method of providing testosterone replacement therapy to a woman in need of such therapy comprising applying a testosterone-delivering patch to the skin of said woman which patch transdermally delivers 50 to 500 .mu.g/day of testosterone to the woman.
    Type: Grant
    Filed: August 3, 1993
    Date of Patent: October 24, 1995
    Assignee: TheraTech, Inc.
    Inventors: Charles D. Ebert, Dinesh C. Patel, Norman A. Mazer, Srinivasan Venkateshwaran